May 26, 2013 1:25 AM ET

Pharmaceuticals

Company Overview of Abbott Laboratories, Limited

Company Overview

Abbott Laboratories, Limited, a health care company, discovers, develops, manufactures, and markets pharmaceuticals and medical products in Canada. It offers pharmaceutical products, including treatments for people with HIV; therapies for sufferers of rheumatoid arthritis; drugs for the treatment of people with gastrointestinal diseases and prostate cancer; antibiotics and specialized medicines for managing obesity, thyroid disease, and hypertension. The company also provides medical nutritional products and feeding devices for patients with special dietary needs due to food allergies, injury, or illnesses, such as cancer, respiratory conditions, and gastrointestinal impairment; and medical ...

Detailed Description

8401 Trans-Canada Highway

Saint-Laurent, QC H4S 1Z1

Canada

Founded in 1931

Phone:

514-832-7000

Fax:

514-832-7800

www.abbott.ca

Key Executives for Abbott Laboratories, Limited

Chairman of the Board and Chief Executive Officer
Age: 57
President
Age: 59
Senior Vice President of Vascular
Age: 52
Divisional Vice President of Infectious Diseases & Immunology Development
General Manager of Abott Vascular Canada
Compensation as of Fiscal Year 2012.

Abbott Laboratories, Limited Key Developments

Abbott Laboratories, Limited Announces New FreeStyle InsuLinx Blood Glucose Monitoring System

Abbott Laboratories, Limited announced that its new FreeStyle InsuLinx Blood Glucose Monitoring System is now available in diabetes centres and select pharmacies across Canada. It is the first blood glucose monitoring device in North America that offers a mealtime insulin calculator for calculating suggested insulin doses. The FreeStyle InsuLinx System is designed to offer suggested insulin doses, as well as other features specifically intended to assist insulin-using patients in more effectively managing their diabetes. The user-friendly features include a touch screen interface, automated logbook, personalization preferences, and USB connectivity for plug-and-play reports. The FreeStyle InsuLinx System is the newest addition to Abbott's portfolio of glucose monitoring products and is designed for people with diabetes who use mealtime (rapid-acting) insulin. The system offers several features that are designed to enable insulin-using diabetes patients to more effectively manage their condition, including: mealtime (rapid-acting) insulin calculator for calculating a suggested dose; touch screen designed for ease of use; automated logbook; personalization preferences, including weekly messages and pre- and post-meal markers, and the ability to upload a personal photograph to the FreeStyle InsuLinx monitor; USB connectivity for plug-and-play reports; and FreeStyle Auto-Assist software, which is PC- and Mac-compatible, designed to help people with diabetes, health care teams and caregivers manage diabetes with reports, reminders and messages.

Similar Private Companies By Industry

Company Name Region
Ardeo Pharma Inc. Americas
Innovascreen, Inc. Americas
Sanofi-Aventis Canada Inc. Americas
AltaRex Medical Corp. Americas
AquaBounty Canada, Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Abbott Laboratories, Limited, please visit www.abbott.ca. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.